437 related articles for article (PubMed ID: 12656664)
21. [Manifestations and prognosis of thyrotropin-secreting pituitary adenomas: a case series of three patients].
Latrech H; Rousseau A; Le Marois E; Billaud L; Bertagna X; Azzoug S; Raffin-Sanson ML
Rev Med Interne; 2010 Dec; 31(12):858-62. PubMed ID: 21074296
[TBL] [Abstract][Full Text] [Related]
22. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
Fukuda T; Yokoyama N; Tamai M; Imaizumi M; Kimura H; Tominaga T; Ashizawa K; Kiriyama T; Yoshimine H; Ohishi K; Eguchi K
Intern Med; 1998 Dec; 37(12):1027-30. PubMed ID: 9932634
[TBL] [Abstract][Full Text] [Related]
23. Clinical and morphological features of undifferentiated monomorphous GH/TSH-secreting pituitary adenoma.
Skorić T; Korsić M; Zarković K; Plavsić V; Besenski N; Breskovac L; Giljević Z; Paladino J
Eur J Endocrinol; 1999 Jun; 140(6):528-37. PubMed ID: 10366409
[TBL] [Abstract][Full Text] [Related]
24. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.
Horiguchi K; Yamada M; Umezawa R; Satoh T; Hashimoto K; Tosaka M; Yamada S; Mori M
Endocr J; 2007 Jun; 54(3):371-8. PubMed ID: 17420609
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
Kuhn JM; Arlot S; Lefebvre H; Caron P; Cortet-Rudelli C; Archambaud F; Chanson P; Tabarin A; Goth MI; Blumberg J; Catus F; Ispas S; Beck-Peccoz P
J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
[TBL] [Abstract][Full Text] [Related]
26. Ectopic pituitary adenoma of the TSH-secreting sphenoidal sinus with excellent response to somatostatin analogs. Theory of the embryogenesis and literature review from a clinical case.
Ortiz E; Peldoza M; Monnier E; Gejman R; Henriquez M; Barra MI; Gayoso R; Sapunar J; Villaseca M; Guzmán P
Steroids; 2020 Feb; 154():108535. PubMed ID: 31704334
[TBL] [Abstract][Full Text] [Related]
27. Medical management of thyrotropin-secreting pituitary adenomas.
Beck-Peccoz P; Persani L
Pituitary; 2002; 5(2):83-8. PubMed ID: 12675505
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of the long-acting octreotide formulation in patients with thyroid-stimulating hormone-secreting pituitary adenomas after incomplete surgery and octreotide treatment failure.
Zhang CF; Liang D; Zhong LY
Chin Med J (Engl); 2012 Aug; 125(15):2758-63. PubMed ID: 22931988
[TBL] [Abstract][Full Text] [Related]
29. Thyrotropin-secreting pituitary adenomas.
Beck-Peccoz P; Persani L; Mantovani S; Cortelazzi D; Asteria C
Metabolism; 1996 Aug; 45(8 Suppl 1):75-9. PubMed ID: 8769389
[TBL] [Abstract][Full Text] [Related]
30. [Thyrotropin--TSH secreting pituitary tumor].
Zieliński G; Podgórski JK; Warczyńska A; Koziarski A; Zgliczyński W
Przegl Lek; 2002; 59(12):1018-23. PubMed ID: 12731380
[TBL] [Abstract][Full Text] [Related]
31. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients.
Wynne AG; Gharib H; Scheithauer BW; Davis DH; Freeman SL; Horvath E
Am J Med; 1992 Jan; 92(1):15-24. PubMed ID: 1346235
[TBL] [Abstract][Full Text] [Related]
32. Thyrotropin-secreting pituitary adenomas: report of seven cases.
Beckers A; Abs R; Mahler C; Vandalem JL; Pirens G; Hennen G; Stevenaert A
J Clin Endocrinol Metab; 1991 Feb; 72(2):477-83. PubMed ID: 1704011
[TBL] [Abstract][Full Text] [Related]
33. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
35. TSH producing pituitary tumor: biochemical diagnosis and long-term medical management with octreotide.
Chayen SD; Gross D; Makhoul O; Glaser B
Horm Metab Res; 1992 Jan; 24(1):34-8. PubMed ID: 1612557
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
Gatto F; Grasso LF; Nazzari E; Cuny T; Anania P; Di Somma C; Colao A; Zona G; Weryha G; Pivonello R; Ferone D
Pituitary; 2015 Oct; 18(5):583-91. PubMed ID: 25326851
[TBL] [Abstract][Full Text] [Related]
37. Thyroid-stimulating hormone pituitary adenomas and hyperthyroidism.
Grisoli F; Leclercq T; Winteler JP; Jaquet P; Guibout M; Diaz-Vasquez P; Hassoun J; Nayak R
Surg Neurol; 1986 Apr; 25(4):361-8. PubMed ID: 3952630
[TBL] [Abstract][Full Text] [Related]
38. ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
De Herdt C; Philipse E; De Block C
Eur J Endocrinol; 2021 Jul; 185(2):R65-R74. PubMed ID: 34132199
[TBL] [Abstract][Full Text] [Related]
39. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
40. [Thyroid-stimulating hormone hypophyseal adenoma. A case report].
Gannage MH; Maacaron C; Okais N; Halaby G
J Med Liban; 1997; 45(2):97-101. PubMed ID: 9289506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
